These data indicated that the treatment with DSF/Cu complex had the greater efficacy in tumor growth inhibition compared with DDP groups whether in LGR5-positive or LGR5-negative cervical cancer cells in vivo. This evidence concerns the gene LGR5 and cervical carcinoma.